SAM ALTMAN-BACKED RETRO BIOSCIENCES STARTS ALZHEIMER'S REVERSAL TRIAL

Summary from the TLDR newsletter

Retro Biosciences is gearing up for a clinical trial of a drug aimed at reversing the effects of Alzheimer's disease. The drug could potentially restore cognitive function in ways that could redefine longevity treatments. Retro's approach leverages cellular reprogramming techniques. The upcoming trial will test the pill's efficacy in human subjects.